EXCAX
Price
$16.82
Change
-$0.00 (-0.00%)
Updated
Jun 12 closing price
Net Assets
3.67B
FCMAX
Price
$12.36
Change
-$0.00 (-0.00%)
Updated
Jun 12 closing price
Net Assets
1.87B
Interact to see
Advertisement

EXCAX vs FCMAX

Header iconEXCAX vs FCMAX Comparison
Open Charts EXCAX vs FCMAXBanner chart's image
EXCAX vs FCMAX Comparison Chart in %
View a ticker or compare two or three
VS
EXCAX vs. FCMAX commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EXCAX is a Hold and FCMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
EXCAX has more cash in the bank: 3.67B vs. FCMAX (1.87B). EXCAX pays higher dividends than FCMAX: EXCAX (3.31) vs FCMAX (2.70). EXCAX was incepted earlier than FCMAX: EXCAX (9 years) vs FCMAX (24 years). FCMAX (0.76) is less costly to investors than EXCAX (0.29). EXCAX is a more actively managed with annual turnover of: 32.00 vs. FCMAX (19.00). FCMAX has a lower initial minimum investment than EXCAX: FCMAX (0) vs EXCAX (1000000). FCMAX annual gain was more profitable for investors over the last year : 6.56 vs. EXCAX (3.51). FCMAX return over 5 years is better than : 2.99 vs. EXCAX (-8.38).
EXCAXFCMAXEXCAX / FCMAX
Total Expense Ratio0.290.7638%
Annual Report Gross Expense Ratio0.290.7638%
Fund Existence9 years24 years-
Gain YTD0.1190.96212%
Front LoadN/A4%-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.67B1.87B196%
Annual Yield % from dividends3.312.70123%
Returns for 1 year3.516.5654%
Returns for 3 years3.5911.6631%
Returns for 5 years-8.382.99-281%
Returns for 10 yearsN/A17.00-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VSME1.690.58
+52.25%
VS Media Holdings Limited
PENN21.680.47
+2.22%
PENN Entertainment
NRIM25.800.28
+1.10%
Northrim BanCorp
BEN32.130.32
+1.01%
Franklin Resources
PTHS27.50-1.22
-4.25%
Pelthos Therapeutics Inc